T1	Nutrient 9 22	dietary fibre
T2	Methodology 104 186	randomised, double-blind, placebo-controlled, cross-over, human intervention study
T3	Disease 189 198	Dysbiotic
T4	Nutrient 71 100	inulin-type fructan prebiotic
T5	DietPattern 579 596	low dietary fibre
T6	DietPattern 598 601	LDF
T7	DietPattern 606 624	high dietary fibre
T8	DietPattern 626 629	HDF
T9	Nutrient 679 708	inulin-type fructan prebiotic
T10	Methodology 718 780	randomised, double-blind, placebo-controlled, cross-over study
T11	DietPattern 834 837	LDF
T12	DietPattern 841 844	HDF
T13	Methodology 884 918	16S rRNA bacterial gene sequencing
T14	DietPattern 1182 1185	LDF
T15	DietPattern 1276 1279	HDF
T16	INCREASES 1324 1332	increase
T17	Microorganism 1336 1351	Bifidobacterium
T18	Microorganism 1366 1382	Faecalibacterium
T19	DECREASES 1397 1406	decreases
T20	Microorganism 1410 1421	Coprococcus
T21	Microorganism 1453 1465	Ruminococcus
T22	DietPattern 1542 1545	HDF
T23	POS_ASSOCIATED_WITH 1611 1633	more likely to benefit
T24	Nutrient 1642 1671	inulin-type fructan prebiotic
T25	DietPattern 1688 1691	LDF
T26	Nutrient 1788 1817	inulin-type fructan prebiotic
T27	Nutrient 1840 1853	dietary fibre
T28	Metabolite 924 928	SCFA
T29	Nutrient 985 994	prebiotic
T30	Nutrient 1012 1027	Orafti® Synergy
T31	Nutrient 1051 1060	Glucidex®
T32	Population 794 814	healthy participants
T33	Nutrient 1197 1206	prebiotic
T34	INCREASES 1230 1238	increase
T35	Microorganism 1242 1257	Bifidobacterium
T36	Nutrient 1291 1300	prebiotic
T37	Microorganism 1433 1438	Dorea
E1	INCREASES:T16 Agent:T15 Theme:T17
E2	DECREASES:T19 Agent:T15 Theme:T20
E3	POS_ASSOCIATED_WITH:T23 Agent:T22 Theme:T24
E4	INCREASES:T16 Agent:T15 Theme:T18
E5	DECREASES:T19 Agent:T15 Theme:T21
E6	INCREASES:T34 Theme:T35 Agent:T14
E7	DECREASES:T19 Theme:T37 Agent:T15
A1	Factuality E3 Probable